Abilify vs. Rexulti: Differences, similarities, and which is better for you

Abilify and Rexulti treat schizophrenia and depression, but they are not the same. Compare side effects and cost to find out which one is better.

Mechanism of action of brexpiprazole: comparison with aripiprazole, CNS Spectrums

Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial - The Lancet Psychiatry

Not Everyone Agreed With FDA Approval of Antipsychotic Rexulti for Agitation - Mad In America

Identification of metabolites of brexpiprazole in human urine for use in monitoring patient compliance - ScienceDirect

ABILIFY® (aripiprazole)

Summary - Pharmacoeconomic Review Report: Brexpiprazole (Rexulti) - NCBI Bookshelf

First FDA Approved Medication for Agitation Associated with Alzheimer's Dementia – Psychiatry Education Forum

Mechanism of action of brexpiprazole: comparison with aripiprazole, CNS Spectrums

Comparison of aripiprazole and risperidone effectiveness in first episode non-affective psychosis: Rationale and design of a prospective, randomized, 3-phase, investigator-initiated study (PAFIP-3)

Antipsychotics - Gateway Psychiatric

Brexpiprazole: “an awakening” (Case 19) - Case Studies: Stahl's Essential Psychopharmacology

Table 1 from Brexpiprazole (Rexulti): A New Monotherapy for Schizophrenia and Adjunctive Therapy for Major Depressive Disorder.